Eμ-Myc lymphoma mainly occurs after the acquisition of the secondary mutations, including those that inhibit tumor suppressor genes, such as p53 and ADP-ribosylation factor (ARF) (145–147). The gene discussed is TP53; the disease is erythema multiforme.